BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2279470)

  • 1. A comparative study of the infectivity of T.b. rhodesiense isolates from man to 3 species of small laboratory rodents.
    Rickman R; Kanyangala S
    East Afr Med J; 1990 Jun; 67(6):413-8. PubMed ID: 2279470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Grammomys surdaster thicket rats to Trypanosoma brucei gambiense infection.
    Büscher P; Bin Shamamba SK; Ngoyi DM; Pyana P; Baelmans R; Magnus E; Van Overmeir C
    Trop Med Int Health; 2005 Sep; 10(9):850-5. PubMed ID: 16135191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigations on the susceptibility of Mastomys natalensis to Trypanosoma (trypanozoon) brucei gambiense (author's transl)].
    Mehlitz D
    Tropenmed Parasitol; 1978 Mar; 29(1):101-7. PubMed ID: 644653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and propagation of Trypanosoma brucei gambiense from sleeping sickness patients in south Sudan.
    Maina NW; Oberle M; Otieno C; Kunz C; Maeser P; Ndung'u JM; Brun R
    Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):540-6. PubMed ID: 17275053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of Trypanosoma brucei, T. rhodesiense, and T. gambiense by the indirect fluorescent antibody test.
    Latif BM; Adam KM
    Bull World Health Organ; 1973; 48(4):401-7. PubMed ID: 4587481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of human serum sensitivity in the context of T.B. rhodesiense sleeping sickness epidemiology and control.
    Rickman LR
    East Afr Med J; 1992 May; 69(5):272-8. PubMed ID: 1644047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in the test responses of clone -- derived Trypanosoma (Trypanozoon) brucei brucei and T.(T).b. rhodesiense relapse antigenic variants, examined by a modified blood incubation infectivity test and its possible significance in Rhodesian sleeping sickness transmission.
    Rickman LR
    Med J Zambia; 1977; 11(2):31-7. PubMed ID: 878630
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification by the blood incubation infectivity test of Trypanosoma brucei subspecies isolated from game animals in the Luangwa Valley, Zambia.
    Awan MA
    Acta Trop; 1979 Dec; 36(4):343-7. PubMed ID: 44098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of some African game animal sera on Trypanosoma brucei rhodesiense and T.b. brucei clones.
    Rickman L; Kolala F
    Tropenmed Parasitol; 1982 Jun; 33(2):129-35. PubMed ID: 7051497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multiplex PCR that discriminates between Trypanosoma brucei brucei and zoonotic T. b. rhodesiense.
    Picozzi K; Carrington M; Welburn SC
    Exp Parasitol; 2008 Jan; 118(1):41-6. PubMed ID: 17643434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The population genetics of Trypanosoma brucei and the origin of human infectivity.
    MacLeod A; Tait A; Turner CM
    Philos Trans R Soc Lond B Biol Sci; 2001 Jul; 356(1411):1035-44. PubMed ID: 11516381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of severe combined immuno-deficient (SCID) mice to Trypanosoma brucei gambiense and T. b. rhodesiense.
    Inoue N; Narumi D; Mbati PA; Hirumi K; Situakibanza NT; Hirumi H
    Trop Med Int Health; 1998 May; 3(5):408-12. PubMed ID: 9623947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The investigation of Trypanosoma brucei isolates obtained from Glossina pallidipes in South Nyanza, Kenya.
    Otieno LH; Darji N
    J Trop Med Hyg; 1987 Oct; 90(5):259-63. PubMed ID: 3669129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of Trypanosoma (Trypanozoon) rhodesiense from game and domestic animals in Musoma District, Tanzania.
    Geigy R; Kauffmann M; Mayende JS; Mwambu PM; Onyango RJ
    Acta Trop; 1973; 30(1):49-56. PubMed ID: 4144957
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative pathogenicity of Trypanosoma brucei rhodesiense strains in Swiss white mice and Mastomys natalensis rats.
    Muchiri MW; Ndung'u K; Kibugu JK; Thuita JK; Gitonga PK; Ngae GN; Mdachi RE; Kagira JM
    Acta Trop; 2015 Oct; 150():23-8. PubMed ID: 26099681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
    Gehrig S; Efferth T
    Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary efficacy trial of Cymelarsan in mice artificially infected with Trypanosoma brucei brucei isolated from a dog in Zambia.
    Syakalima M; Yasuda J; Hashimoto A
    Jpn J Vet Res; 1995 Sep; 43(2):93-7. PubMed ID: 7474644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental infection with two stocks of Trypanosoma brucei gambiense. Study of the evolution by elution techniques of tissues.
    Mulumba PM; Wéry M
    Contrib Microbiol Immunol; 1983; 7():120-9. PubMed ID: 6825435
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation of human serum resistant Trypanozoon from cattle in Nigeria.
    Joshua RA; Magaji Y; Kayit YS
    Tropenmed Parasitol; 1983 Sep; 34(3):201-2. PubMed ID: 6636302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical assessment of the entry into neurological state in rat experimental African trypanosomiasis.
    Chevrier C; Canini F; Darsaud A; Cespuglio R; Buguet A; Bourdon L
    Acta Trop; 2005 Jul; 95(1):33-9. PubMed ID: 15882835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.